How many insider declarations does UCB have?

UCB has filed 50 insider declarations with FSMA.

Who is the top reporting insider at UCB?

The top reporting insider at UCB is Caeymaex Emmanuel, based on the count of public filings.

What is the net insider buy vs sell volume on UCB?

Across the available history, declared buys total 4.4M€ and disposals 17.8M€.

What is the ISIN of UCB?

The ISIN of UCB is BE0003739530.

InsidersTradesSigma

← Companies ★ Sign in to follow

UCB: insider trades · Belgium · FSMA

FSMA:ucbBE0003739530BE·FSMAMcap 45.1Bn€Healthcare & Pharma

AMF ↗

Discover the full directors' dealings record of UCB, a publicly traded company based in Belgium. Shares are listed on BE BE, under the authority of FSMA. Operating in the Healthcare & Pharma sector, UCB has logged 50 public disclosures. Market capitalisation: €45.1bn. The latest transaction was filed on 13 April 2026 — Sale. Among the most active insiders: Caeymaex Emmanuel. All data is openly available.

50

Insider Decl.

0

Thresholds

€4m

35 ops.

Buy Volume

€18m

14 ops.

Sell Volume

Financial data

237.00 €

Analyst consensus

19 analysts

Buy

195.00 €Target 288.21 €(+22%)340.00 €

Valuation

PER (trailing)29.5x

PER (forward)17.4x

P/Book4.2x

Beta0.17

Balance sheet & cash

Market cap45.12 Bn€

Debt / Equity21%

Profitability & ownership

ROE14.9%

ROA7.0%

% insiders36.3%

% institutions39.8%

Last declaration on 13 April 2026

All Executives50 Thresholds Prospectus Other

Declarations0 total

No declarations found

0 of 0 declarations

About UCB

UCB is a Belgian biopharmaceutical company focused on developing medicines for severe diseases. It is listed on the Brussels stock market (XBRU).

GBL

Finance & Banking

UCB: insider trades · Belgium · FSMA

Financial data

About UCB

Similar companies

Related executives